Progesterone’s role in frozen embryo transfers
Progesterone is currently administered by vaginal gels, creams or inserts or with injections into a muscle. These methods can be painful, messy and stressful. Carolina Conceptions is currently recruiting patients for a clinical trial sponsored by IBSA Group that is researching easier ways to administer the hormone progesterone, which plays a vital role in pregnancy and frozen embryo transfers (FET).
Eligible subjects will have their frozen #embryo transfer (FET) cycle covered.
Who is eligible to help us make progress?
- Women ages 35-42.
- Have regular menstrual cycles (24-38 days).
- Are planning a single embryo transfer.
- Have completed a normal uterine cavity evaluation, such as hysteroscopy, hysterosalpingogram, or SIS, within the past year.
- Have a normal pap smear.
Eligible participants who join the study will:
- Attend scheduled clinic visits.
- Have blood drawn to evaluate hormone levels.
- Complete transvaginal ultrasounds designed to monitor changes to the ovaries, uterine lining or pregnancy, if applicable.
- Receive study medications to self-administer as instructed by the clinic staff.
For a complete list of eligibility criteria, visit ClinicalTrials.gov: NCT04549116 or visit progressivfstudy.com for more information.
